- Home
- BPTH
as 11-22-2024 2:32pm EST
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BELLAIRE |
| Market Cap: | 4.0M | IPO Year: | N/A |
| Target Price: | $30.00 | AVG Volume (30 days): | 114.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $0.61 - $12.40 | Next Earning Date: | 11-15-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Bio-Path Holdings Inc. News
BPTH Breaking Stock News: Dive into BPTH Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 days ago
Bio-Path Holdings Inc (BPTH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial ...
Associated Press Finance
7 days ago
Bio-Path: Q3 Earnings Snapshot
GlobeNewswire
7 days ago
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
GlobeNewswire
14 days ago
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
MT Newswires
a month ago
Bio-Path Closes $4 Million Private Equity Offering
GlobeNewswire
a month ago
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GuruFocus.com
a month ago
Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ...
MT Newswires
a month ago
Bio-Path Launches $4 Million Private Placement of Shares, Warrants; Shares Fall
Compare BPTH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BPTH Bio-Path Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.